Recombinant multi-species DGKA protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine DGKA protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene belongs to the eukaryotic diacylglycerol kinase family. It acts as a modulator that competes with protein kinase C for the second messenger diacylglycerol in intracellular signaling pathways. It also plays an important role in the resynthesis of phosphatidylinositols and phosphorylating diacylglycerol to phosphatidic acid. Several transcript variants encoding different isoforms have been identified for this gene. [provided by RefSeq, Apr 2017]
The Alternative Names of target: 80 kDa diacylglycerol kinase,80kDa,DAG kinase alpha,DAGK,DAGK1,DGK-alpha,DGKA,Dagk1,Dgka,Diacylglycerol kinase alpha,Diglyceride kinase alpha (DGK-alpha)

Target products collectionGo to DGKA products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP6021-Ag-1/ GM-Tg-hg-IP6021-Ag-2 Human DGKA protein Human
GM-Tg-rg-IP6021-Ag-1/ GM-Tg-rg-IP6021-Ag-2 Rat DGKA protein Rat
GM-Tg-mg-IP6021-Ag-1/ GM-Tg-mg-IP6021-Ag-2 Mouse DGKA protein Mouse
GM-Tg-cynog-IP6021-Ag-1/ GM-Tg-cynog-IP6021-Ag-2 Cynomolgus/Rhesus macaque DGKA protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP6021-Ag-1/ GM-Tg-felg-IP6021-Ag-2 Feline DGKA protein Feline
GM-Tg-cang-IP6021-Ag-1/ GM-Tg-cang-IP6021-Ag-2 Canine DGKA protein Canine
GM-Tg-bovg-IP6021-Ag-1/ GM-Tg-bovg-IP6021-Ag-2 Bovine DGKA protein Bovine
GM-Tg-equg-IP6021-Ag-1/ GM-Tg-equg-IP6021-Ag-2 Equine DGKA protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP6021-Ag-1/ GM-Tg-hg-IP6021-Ag-2; GM-Tg-rg-IP6021-Ag-1/ GM-Tg-rg-IP6021-Ag-2;
GM-Tg-mg-IP6021-Ag-1/ GM-Tg-mg-IP6021-Ag-2; GM-Tg-cynog-IP6021-Ag-1/ GM-Tg-cynog-IP6021-Ag-2;
GM-Tg-felg-IP6021-Ag-1/ GM-Tg-felg-IP6021-Ag-2; GM-Tg-cang-IP6021-Ag-1/ GM-Tg-cang-IP6021-Ag-2;
GM-Tg-bovg-IP6021-Ag-1/ GM-Tg-bovg-IP6021-Ag-2; GM-Tg-equg-IP6021-Ag-1/ GM-Tg-equg-IP6021-Ag-2
Products Name DGKA protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name DGKA
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine DGKA protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.